funded by grants from the Shanghai Science Committee Foundation(No.19411967700);the National Natural Science Foundation of China(No.31570993);the Wu Jieping Medical Foundation(No.320.6750.2020-14-7).
To the Editor:In recent years,the treatment for metastatic hormone-sensitive prostate cancer(mHSPC)has undergone rapid developments.Docetaxel(DOC)or androgen receptor-targeted agent(ARTA)and androgen deprivation thera...
the grants from the Natural Science Foundation of Shandong Province,the Science and Technology Research Foundation of Jinan City
Prostate cancer is one of the leading causes of death in male in western countries; in addition, recently, the incidence of prostate cancer has increased rapidly in China. There are considerable variations between pra...